Table 1 Patients treated with front-line anthracycline + ifosfamide chemotherapy: clinical characteristics and response evaluation
Patients ID | Gender | Age at time of diagnosis (years) | Myxofibrosarcoma grade | Site of primary tumour | Site of relapse at time of CT | Response evaluation criteria in solid tumours (RECIST) evaluation |
|---|---|---|---|---|---|---|
1 | M | 53 | 2 | Left thigh | Lung | PR |
2 | F | 72 | 2 | Right arm | Right arm | SD |
3 | M | 71 | 3 | Thoracic wall | Lung | PD |
4 | F | 33 | 3 | Abdomen | Lung and abdomen | PR |
5 | F | 48 | 1 | Left thigh | Left thigh | SD |
6 | F | 64 | 1 | Scalp | Scalp | PR |
7 | M | 55 | 2 | Thoracic wall | Lung | PD |
8 | F | 44 | 3 | Right thigh | Right thigh | PD |
9 | F | 51 | 3 | Left thigh | Lung | SD |
10 | M | 64 | 2 | Abdomen | Lung | PD |
11 | M | 64 | 2 | Left thigh | Lung | PD |
12 | F | 33 | 3 | Left thigh | Lung and abdomen | PD |
13 | M | 48 | 2 | Right thigh | Lung | PR |